Dyne Therapeutics, Inc. logo DYN - Dyne Therapeutics, Inc.

NEXT EARNINGS: Feb 26, 2026 (in 4 days)
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 11
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $37.89 DETAILS
HIGH: $60.00
LOW: $23.00
MEDIAN: $39.00
CONSENSUS: $37.89
UPSIDE: 154.64%
Market Cap: 2.41B
Volume: 1,761,417
Avg Volume: 2,464,296
52 Week Range: 6.36-25
Sector: Healthcare
Industry: Biotechnology
Beta: 1.31
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 192
IPO Date: 2020-09-17
EPS (TTM): -3.37
P/E Ratio: -6.99
Revenue (TTM): N/A
Total Assets: 691.23M
Total Debt: 23.99M
Cash & Equiv: 435.45M
Rev Growth (5Y): N/A
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -48.9%
Debt/Equity: 0.04

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue 0 0 0 0 0 0 0 506.00M 1.37B 842.00M 1.47B 3.00M
Net Income (317.42M) (235.94M) (168.10M) (149.29M) (58.74M) (13.54M) (4.81M) 76.00M (1.24B) 50.00M (67.00M) (356.00M)
EPS -3.37 -3.95 -3.23 -2.93 -1.24 -0.30 -0.47 0.47 -9.61 0.40 -0.53 -3.56
Total Assets 691.23M 165.08M 306.32M 425.66M 353.33M 16.44M 8.27M 11.77B 13.05B 11.54B 11.23B 5.29B
Total Debt 23.99M 27.41M 30.48M 32.64M 0 0 3.38M 8.43B 8.98B 7.29B 7.11B 1.99B
Cash & Equivalents 435.45M 121.63M 172.15M 200.82M 300.85M 14.63M 8.12M 365.00M 1.78B 505.00M 1.87B 843.00M
Operating Cash Flow (292.37M) (188.16M) (153.65M) (119.56M) (46.51M) (11.83M) (4.16M) 585.00M 676.00M 94.00M (62.00M) 175.00M
Free Cash Flow (294.75M) (188.89M) (156.71M) (123.18M) (47.67M) (13.48M) (4.30M) 361.00M 350.00M (181.00M) (62.00M) 77.00M
FCF per Share -3.13 -3.16 -3.02 -2.42 -1.01 -0.30 -0.42 2.23 2.71 -1.45 -0.49 0.77
Book Value 629.84M 91.29M 252.36M 368.20M 342.37M 14.04M (4.88M) 1.90B 2.04B 2.92B 3.02B 2.21B
Cash & ST Investments 642.27M 123.10M 256.01M 376.57M 345.31M 14.63M 8.12M 397.00M 1.91B 605.00M 1.95B 868.00M
ROC Equity -0.50 -2.58 -0.67 -0.41 -0.17 -0.96 N/A 0.04 -0.61 0.02 -0.02 -0.16